Bemaj Pharmacy

Are there any homeopathy remedies for neck pain? – Yes, homeopathic medicine can help relieve neck pain. Cimicifuga, Chelidonium, and Causticum are all effective treatments for neck pain. Homeopathic treatment can help with both acute and chronic neck pain.

What is the homeopathic medicine for neck pain and headache?

Gelsemium – Effective Homeopathic Medicine for Neck Pain with Headache – Gelsemium is a natural remedy prepared from the bark of the root of a plant called ‘Yellow Jasmine.’ The natural order of this plant is Loganiaceae. Gelsemium remains highly effective for cases of a stiff neck with a headache.

Which homeopathic drop for cervical pain?

Information about SBL Drops No.5 (For Cervical Pain) – SBL drops no.5 is used when patient complaining of pain in the neck, around shoulder blade which may extend down the arm, Neck stiffness, Headache, Vertigo, Numbness, Muscle weakness, vertigo and numbness in arms and fingers.

• SBL drops no.5 brings prompt relief in cervical pain and associated symptoms.
• Composition: Bryonia alba3x, Cimicifuga racemosa3x, Colocynthis 3x, Hypericum perforatum3x, Ledum palusre3x, Ruta graveolens3x.
• Recommended Dosage: 10-15 drops in the 1/4th cup of water, 3-4 times a day or as prescribed by the physician.

Side effects: No side effects are known. Precautions: 1. Maintain half an hour gap between food/drinks/other medications and the prescribed homeopathic medicine.2. While on homeopathic medication, there shouldn’t be any strong smell like that of an onion, garlic, camphor, coffee, hing, in your mouth.3.

1. Avoid use of alcohol and tobacco while on homeopathic medication.4.
2. Store homeopathic remedies away from strong odors such as menthol, mint, camphor, essential oils, lip balm, deep heat liniments, cough lozenges, chewing gum, aromatic toothpaste, chemical fumes, perfumes etc.
3. Use under medical supervision.

Country of origin: India Expires on or after: August, 2027 A licensed vendor partner from your nearest location will deliver SBL Drops No.5 (For Cervical Pain). Once the pharmacy accepts your order, the details of the pharmacy will be shared with you.

What is the homeopathic medicine for left shoulder to neck pain?

What is the best homeopathic remedy for shoulder pain? – Homeopathic remedies for shoulder pain may include Sanguinaria Can, Ferrum Met, Rhus Toxicodendron, Phytolacca Decandra, Colchicum, Bryonia Alba, and Ruta Graveolens, We recommend consulting an experienced Homeopathy doctor who will study the symptoms and recommend appropriate homeopathy medicines for shoulder pain.

Which medicine is best for neck pain?

Pain Relief Medications – Some neck pain may be due to inflammation in the discs of the spine and the surrounding nerves and joints. Nonsteroidal anti-inflammatory drugs (NSAIDs) alleviate pain by reducing inflammation. NSAIDs include ibuprofen, naproxen, and aspirin, all of which are available over-the-counter.

Is Arnica good for neck pain?

Does arnica help with pain? – Historically, Arnica has been used to treat inflammation, rheumatism, bruises and sprains. Nowadays, research proves that its anti-inflammatory properties can provide localised healing and targeted pain relief for muscle aches and pains, osteoarthritic pain, and post-surgical pain, and can help relieve other pains including back pain, neck and shoulder pain and knee pain.

Is Rhus tox good for cervical spondylosis?

Lifestyle Changes To Manage Cervical Spondylosis And Neck Pain –

• Adopting a few lifestyle measures can help better manage complaints of cervical spondylosis and neck pain. These measures include:
• Regular exercise
• Physiotherapy that helps strengthen the neck muscles and maintain flexibility of the cervical spine
• Maintaining correct posture while sitting, lying down
• Avoiding job or work that puts stress/strain on the neck
• Avoiding lifting heavy weights
• Warm applications and neck massages can help
• Avoid putting thick pillows or too many pillows under the head while sleeping

: 5 Best Homeopathic Medicines For Cervical Spondylosis And Neck Pain

What does Rhus tox do?

Homeopathic Rhus toxicodendron treatment increased the expression of cyclooxygenase-2 in primary cultured mouse chondrocytes , October 2013, Pages 248-253 Rhus toxicodendron ( Rhus tox ) is another name for the plant Toxicodendron pubescens,1 Rhus tox has been extensively used as a traditional homeopathic remedy for inflammatory conditions, including skin eruption, back pain and stiffness, irritability and restlessness, and rheumatoid arthritis.2, 3, 4 Rhus tox contains a potent allergen called Urushiol, which is present in the resinous sap of this plant and causes contact dermatitis.5, 6 Recent studies have demonstrated the anti-inflammatory and immunomodulatory effects of Rhus tox in experimental animal models.1, 4, 6 These studies reported that homeopathic dilutions of 6c, 30c and 200c Rhus tox show anti-inflammatory activity, involving histamine and prostaglandin, thus modulating anti-arthritis.1, 4 The previously reported effects of homeopathic dilutions of Rhus tox were primarily demonstrated through clinical trials using animal models.

• Here, we investigated the gene expression of primary cultured mouse chondrocytes stimulated with Rhus tox using reverse transcription polymerase chain reaction (RT-PCR) and quantitative (or real-time) RT-PCR (qRT-PCR).
• Nucleic amplification methods are important in basic research, pharmacogenomics and molecular diagnostics.7 Reverse transcription (RT), followed by PCR, is a technique used for the analysis of mRNA expression.8 This method uses gene-specific primers and internal competitor template sets to amplify the target gene and generate conventional RT-PCR products.

The quantification of mRNA levels through RT-PCR is an exquisitely sensitive technique, facilitating the analysis of gene expression from small amounts of RNA.9 The target gene mRNA levels are measured relative to their respective competitor templates, and the measurement of the expression of each gene expression mediates the direct comparison between experiments.7 Therefore, we applied RT-PCR and qRT-PCR to examine the mRNA expression of collagen type II, which is a unique marker protein for differentiated chondrocytes, and the expression and activity of cyclooxygenases-2 (COX-2), a major inflammatory mediator in arthritis, in primary cultured mouse chondrocytes.

• COX exists as two isoforms, COX-1 and COX-2.10 COX-1 is constitutively expressed in most tissues, 10 and COX-2 is stimulated through inflammatory signals; thus, COX-2 expression is primarily involved in inflammation.
• COX-2 is responsible for the synthesis of the prostanoids (prostaglandins and thromboxanes) involved in pathological processes.10, 11, 12 COX-2 promotes the release of the pro-inflammatory mediator prostaglandin E2 (PGE2), and COX-2 inhibitors suppress PGE2 production.13 The results of the present study showed that the stimulation of Rhus tox in mouse chondrocytes increased COX-2 mRNA and protein expression and enhanced PGE2 production.

The liquid dilutions of Rhus tox at 4×, 30×, 30c, and 200c were purchased from Boiron (Newtown Square, PA, USA) and used for 1:10 dilutions in cell culture media according to the manufacturer’s instructions. In addition, the liquid form of Rhus tox was supplied in 20% ethanol (EtOH), and we prepared a 20% (v/v) EtOH solution for use in the 1:10 dilution.

A final concentration of 2% (v/v) EtOH solution in the cell culture media was used in the control group. Unless otherwise mentioned, all The cytotoxic effects of Rhus tox on primary cultured mouse chondrocytes were evaluated using the MTT colorimetric assay.17 Briefly, the cells were stimulated with 2% EtOH or 4×, 30×, 30c or 200c homeopathic dilutions of Rhus tox for 48 h, and the cell proliferation was analyzed (Figure 1).

As shown in Figure 1, stimulation with a homeopathic dilution of Rhus tox did not affect the survival and proliferation of chondrocytes, although the 4× Rhus tox treatment slightly inhibited cell growth. To Many clinical trials and studies have demonstrated the effectiveness of homeopathic remedies using experimental animal models.6, 18, 19 Among the most common homeopathic remedies, Rhus tox has been used to treat joint pain with stiffness.

Rhus tox typically causes muscular, articular, and ligament pain and induces dermatitis.1 However, Patil et al. demonstrated that homeopathic Rhus tox, in its crude form and diluted to 3, 6, 30 and 200c, possesses immunomodulatory activity in human In this study, we examined the effects of homeopathic Rhus tox treatment in primary cultured mouse chondrocytes.

Homeopathic Rhus tox has been used to treat arthritic pain and to modulate inflammatory conditions. It has been reported that COX-2 is upregulated during inflammation and plays a role in PGE2 production. The results of the present study clearly showed that treatment with a 30× homeopathic dilution of Rhus tox increased COX-2 expression and PGE2 production in primary cultured mouse The authors declare no conflicts of interest.

A.L. dos Santos et al. C.R. Patil et al. Z. Xia et al. C.R. Patil et al. A.W.M. Cheng et al. A.C. Abrahao et al. Y.H. Huh et al. J. Martel-Pelletier et al. F. Denizot et al. C. Chandrakant Nimgulkar et al.

S.M. de Oliveira et al. D.R. Patel et al.

To determine the possible effect of two homeopathic medicines, Ruta graveolens 5CH and Rhus toxicodendron 9CH, in the prevention of aromatase inhibitor (AI) associated joint pain and/or stiffness in women with early, hormone-receptor positive, breast cancer. This prospective, unrandomized observational study was carried out between April and October 2014. Women were recruited in two groups, according to which of the two study centres they attended: one receiving homeopathy in addition to standard treatment (group H) and a control group, receiving standard treatment (group C). All women were treated with an AI. In addition, women in group H also took Ruta graveolens 5CH and Rhus toxicodendron 9CH (5 granules, twice a day) up to 7 days before starting AI treatment. The homeopathic medicines were continued for 3 months. Demographic and clinical data were recorded using a self-assessment questionnaire at inclusion (T0) and 3 months (T3). Primary evaluation criteria were the evolution of scores for joint pain and stiffness, the impact of pain on sleep and analgesic consumption in the two groups after 3 months of treatment. Forty patients (mean age 64.9 ± 8.1 years) were recruited, 20 in each group. Two-thirds of the patients had joint pain before starting AI treatment. There was a significant difference in the evolution of mean composite pain score between T0 and T3 in the two groups (−1.3 in group H vs. +3.4 in group C; p = 0.0001). The individual components of the pain score (frequency, intensity and number of sites of pain) also decreased significantly in group H. Nine patients in group C (45%) vs.1 (5%) in group H increased their analgesic consumption between T0 and T3 (p = 0.0076). After 3 months of treatment, joint pain had a worse impact on sleep in patients in group C (35% vs.0% of patients; p = 0.0083). The differences observed in the evolution of morning and daytime stiffness between the two groups were smaller (p = 0.053 and p = 0.33, respectively), with the exception of time necessary for the disappearance of morning stiffness which was greater in group C (37.7 ± 23.0 vs.17.9 ± 20.1 min; p = 0.0173). These preliminary results suggest that treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may decrease joint pain/stiffness in breast cancer patients treated with AIs. A larger-scale randomized study is required to confirm these results. Arnica montana is a popular traditional remedy widely used in complementary medicine, also for its wound healing properties. Despite its acknowledged action in clinical settings at various doses, the molecular aspects relating to how A. montana promotes wound healing remain to be elucidated. To fill this gap, we evaluated the whole plant extract, in a wide range of dilutions, in THP-1 human cells, differentiated into mature macrophages and into an alternative IL-4-activated phenotype involved in tissue remodelling and healing. Real-time quantitative Reverse Transcription Polymerase Chain Reaction (PCR) analysis was used to study the changes in the expression of a customized panel of key genes, mainly cytokines, receptors and transcription factors. On macrophages differentiated towards the wound healing phenotype, A. montana affected the expression of several genes. In particular CXC chemokine ligand 1 (CXCL1), coding for an chief chemokine, exhibited the most consistent increase of expression, while also CXC chemokine ligand 2 (CXCL2), Interleukin8 (IL8) and bone morphogenetic protein (BMP2) were slightly up-regulated, suggesting a positive influence of A. montana on neutrophil recruitment and on angiogenesis. MMP1, coding for a metalloproteinase capable of cleaving extracellular matrix substrates, was down-regulated. Most results showed non-linearity of the dose-effect relationship. This exploratory study provides new insights into the cellular and molecular mechanisms of action of A. montana as a promoter of healing, since some of the genes it modifies are key regulators of tissue remodelling, inflammation and chemotaxis. Standardization and quality control of homeopathic drugs is very challenging. As mother tinctures are derived from complex natural resources, there is a need of systematic evaluation of chemical markers which correlate with the proposed biological activities of mother tinctures. In present study, High-Performance Thin-Layer Chromatography (HPTLC) standardization method of homeopathic mother tinctures of Toxicodendron pubescens using quercitrin and rutin as chemical markers is validated and correlations of content of these markers with its anti-inflammatory effects are established. For HPTLC analysis, precoated silica gel plates were used as stationary phase. Two flavonoids, namely quercitrin and rutin were used as markers. Separation was achieved using methylene chloride:methanol:water:glacial acetic acid (15:1.5:1:8 v/v/v) as mobile phase. The developed plates were scanned at 365 nm. It was observed that quercitrin (Rf value 0.63) and Rutin (Rf value 0.41) are well resolved. The minimum detectable concentrations for quercitrin and rutin were 5 ng/spot. The linearity range was between 100 and 2000 ng/spot for both the markers. Subsequently, anti-inflammatory activity of these formulations was determined against carrageenan-induced paw edema in rats, pain threshold determined by electronic Von-Frey apparatus and paw withdrawal latency (PWL) on hot-plate. All the tested formulations of Rhus Tox showed anti-inflammatory and analgesic activity against carrageenan induced paw edema in rats. Quantitative correlation between the content of markers and anti-inflammatory activity of mother tinctures was established. Results: Anti-inflammatory effect as well as effect on paw withdrawal and pain threshold, at third hour after carrageenan injection, correlated with quercitrin and rutin content in the respective formulations. This study validates a quantitative HPTLC method for standardization of homeopathic mother tincture of Rhus Tox and establishes quercitrin and rutin as markers corresponding its biological activity. Contents of quercitrin and rutin in T. pubescens mother tincture correlates with its anti-inflammatory and analgesic actions and the validated HPTLC method can be used in standardization of homeopathic mother tincture of T. pubescens, Homeopathic remedy Rhus toxicodendron ( Rhus tox ) is used for several symptoms including skin irritations, rheumatic pains, mucous membrane afflictions, and typhoid type fever. Previously, we reported that Rhus tox treatment increased the cyclooxygenase-2 ( COX-2 ) mRNA expression in primary cultured mouse chondrocytes. A preosteoblastic mouse cell line, MC3T3-e1, was treated with different homeopathic dilutions of Rhus tox and the COX-2 mRNA and protein expression was examined using reverse transcriptase-polymerase chain reaction (RT-PCR) and immunoblotting. Additionally, nitric oxide (NO) generation was examined in LPS-induced MC3T3-e1 cells using a Griess reaction assay. Stimulation with different concentrations of Rhus tox increased the expression of Cox2 mRNA, with 30X Rhus tox showing the most prominent increase in mRNA expression. In addition, treatment with 30X Rhus tox significantly increased prostaglandin E2 (PGE2) release compared with other homeopathic dilutions. However, the COX-2 protein expression level differed slightly from its mRNA expression, because the 30C Rhus tox treatment increased COX-2 protein to a greater extent compared with other dilutions. NO generation was dramatically decreased in MC3T3-e1 cells after Rhus tox treatment co-stimulated with lipopolysaccharide. Homeopathic dilution of Rhus tox has a dual activity that increases COX-2 expression and decreases NO generation, thus modulating inflammation. Further study is needed to examine the cellular signaling mechanisms that are associated with inflammatory regulation by Rhus tox treatment in greater detail. Experiments about basic research in Immuno-allergology reported by M. Bastide and B. Poitevin in Ultra High Dilution (1994) have been appraised from a 20 year perspective. The numerous experiments published mainly focus on immunological regulation, inflammatory process and basophil activation. They are analyzed according to one essential criterion: repeatability. The commentary reflects the research details made available in a recently published literature review, also published in French. The regulatory effect of high dilution of bursin on immune response has been observed in multiple experiments but not reproduced by independent teams. The immunomodulating effect of Thymulin has been confirmed in mice. Rhus toxicodendron has an anti-inflammatory activity on different models, from mother tincture (TM) to very high dilutions. The homeopathic complex Canova activates macrophages in vitro and in vivo, induces lymphocyte proliferation, and reduces the size of tumors and mortality of sarcoma-bearing mice. Some homeopathic medicines used in clinical inflammation modulate in vitro the neutrophil activation, with variability in the protocols used and in the medicines tested. In allergology, high dilution histamine has an inhibitory effect on basophil activation in multicenter trials and with independent teams, either with methods implying a change in basophil staining or with flow cytometry. However, high dilution histamine had no effect in some well-conducted experiments. The inhibitory effect of Apis mellifica has not been studied with the flow cytometry method, as well as the activation of basophil by anti-IgE high dilution, published in Nature. Despite considerable research activity in immuno-allergology and a great increase in the number of publications, there is still not in this domain a “gold standard” trial in basic research in homeopathy. The most studied system, the inhibitory effect of histamine high dilutions on basophil activation, requires clarifications of various factors, including individual sensitivity. For scientific and epistemological reasons, the same work should be carried out for independent reproduction of the experiments conducted with anti-IgE and Apis mel high dilution, in complement of the new axes of research in immunoallergology developed since 20 years. In the 1990s, a study was performed on the effects of highly diluted thyroxine on frog metamorphosis. This model represented one of the most discussed examples of the biological effects of high dilutions over the next two decades. In 2010, another critical conceptual review of the use of animal models in homeopathy and high-dilution research was published. The main contribution of these studies was the elucidation of the biological features and phenomenology of the effects of high dilutions on living systems, representing an important step forward in our understanding of the mechanisms of action of homeopathic medicines. We performed a further review of this line of investigation using the same methods. Fifty-three articles that were indexed in the PubMed database and used 12 different animal species were systematically evaluated. Only a fraction of the studies (29/53) reported herein were performed with “ultra high” dilutions. The other studies were performed with dilutions in ranges below 10 −23 (14/53 articles) or commercial complexes (10/53 articles). Only two articles reported negative results; both used in vivo protocols to test commercial complexes, one in fish and one in bees. The quality of the employed techniques improved in 2010–2014 compared with the studies that were reviewed previously in 2010, with the inclusion of more ethically refined protocols, including in vitro primary cell cultures and ex vivo studies (10/53 articles), often with three or more replicates and analyses of epigenetic mechanisms that were previously unknown in 2010. In our updated review of the past 5 years, we found further demonstrations of the biological effects of homeopathy using more refined animal models and in vitro techniques.

Epileptic seizures are characterized by imbalanced inhibition-excitation cycle that triggers biochemical alterations responsible for jeopardized neuronal integrity. Conventional antiepileptic drugs (AEDs) have been the mainstay option for treatment and control; however, symptomatic control and potential to exacerbate the seizure condition calls for viable alternative to these chemical agents. In this context, natural product-based therapies have accrued great interest in recent years due to competent disease management potential and lower associated adversities. Cicuta virosa (CV) is one such herbal remedy that is used in traditional system of medicine against myriad of disorders including epilepsy. Homeopathic medicinal preparations (HMPs) of CV were assessed for their efficacy in pentylenetetrazole (PTZ)-induced acute and kindling models of epilepsy. CV HMPs increased the latency and reduced the duration of tonic-clonic phase in acute model while lowering the kindling score in the kindling model that signified their role in modulating GABAergic neurotransmission and potassium conductance. Kindling-induced impairment of cognition, memory, and motor coordination was ameliorated by the CV HMPs that substantiated their efficacy in imparting sustained neuronal fortification. Furthermore, biochemical evaluation showed attenuated oxidative stress load through reduced lipid peroxidation and strengthened free radical scavenging mechanism. Taken together, CV HMPs exhibited promising results in acute and kindling models and must be further assessed through molecular and epigenomic studies. Toxicodendron vernicifluum (Stokes) F.A. Barkley (syn. Rhus verniciflua or vernicifera Stokes, Anacardiaceae) (RVS), the lacquer tree, also known as sumac, has been used in China, Japan and South Korea for thousands of years as a highly durable coating material and a traditional herbal medicine, which contains medicinal ingredients with anti-tumor, anti-inflammatory, antiviral, and anti-rheumatic activities. This review intends to provide a comprehensive and critical appraisal of RVS, including its phytochemical data, botanical and pharmacological literature that support its therapeutic potential in treatment on human diseases, with emphasis on the isolation of natural occurring compounds and detailed pharmacological investigations. Specific information of RVS was collected by using the key words ” Toxicodendron vernicifluum “, ” Rhus verniciflua Stokes”, ” Rhus vernicifera Stokes” and “Lacquer tree” through published scientific materials (including PubMed, ScienceDirect, Wiley, ACS, CNKI, Scifinder, Springer, Web of Science, Google Scholar, and Baidu Scholar) and other literature sources. The major phytoconstituents, 175 of which are presented in this review, including flavonoids, urushiols, terpenes, phenolic acids and other types of compounds, of which flavonoids and urushiols are main components. The extracts and isolates purified from RVS showed a wide range of in vitro and in vivo pharmacological effects, such as anti-cancer, anti-oxidation, anti-inflammatory, antimicrobial, tyrosinase inhibition and so on. The modern pharmacological research of RVS mainly focus on the pharmacological effects of crude extract or active constituents, of which the flavonoids are widely studied. However, there are few reports on the relationship between pharmacological effects and their structures. And at present, there is still a lack of researches that are of both effective and in-depth. Meanwhile, there is little research on quality control. Apart from the wood and lacquer, other botanical parts also need to be explored further. In addition to phenolic compounds, the study on other types of components in T. vernicifluum would start more sparks for the discovery of new bioactive principles. Homeopathy seeks to treat holistically. The role of homeopathy for treating binge eating however remains poorly explored. To determine the efficacy of individualized homeopathic treatment on binge eating. This was a nine-week pilot study using a case study design. Individualized homeopathic remedies were prescribed to each participant for six weeks and case analysis evaluated changes over time. All participants reported a decrease in the severity and frequency of binging behaviour; concurrent improvements in general health were also noted. This pilot study shows the potential benefits of individualized homeopathic treatment in binge eating in males. This investigation extends our previous dental data collection pilot study with the following main aims: to gain insight into the periodontal complaints that dentists in the UK treat using individualised homeopathic prescription; to record patient-assessed change in severity of treated complaint (acute or chronic); to determine periodontal pocket depth (PPD). Three dentists recorded data systematically at 249 homeopathic appointments in 51 patients over a period of 18 months. A spreadsheet enabled the data collection of the following records: date of appointment; anonymised patient identity; main periodontal problem treated; whether the condition was acute or chronic; patient-assessed clinical outcome on a 7-point Likert scale, ranging from −3 to +3, to compare the first and any subsequent appointments; whether any interventional dental surgery (IDS) had been carried out; clinician-assessed PPD measurements. At least one follow-up (FU) appointment was reported for each of 46 patients (22 chronic ; 24 acute ). In chronic cases, strongly positive outcomes (score of +2 or +3) were reported by 2 (33.3%) of 6 IDS patients and by 1 (6.3%) of 16 non-IDS patients. In acute cases, strongly positive outcomes were reported by 7 (70%) of 10 IDS patients and by 8 (57.2%) of 14 non-IDS patients (no statistically significant difference between sub-groups). The FU conditions most frequently treated with homeopathy were chronic periodontitis (19 patients) and acute periodontal abscess (11 patients). Analysis of PPD data was not feasible due to the small numbers of patients involved. Limited insight has been gained into the periodontal complaints treated by homeopathy in the UK. Due to small sample size and equivocal results, the interpretation of the patient-reported outcomes data is unclear. Positive findings obtained in the acute treatment setting suggest that this may be a promising area for research in periodontal homeopathy. Arnica montana is a popular traditional remedy widely used in complementary medicine, also for its wound healing properties. Despite its acknowledged action in clinical settings at various doses, the molecular aspects relating to how A. montana promotes wound healing remain to be elucidated. To fill this gap, we evaluated the whole plant extract, in a wide range of dilutions, in THP-1 human cells, differentiated into mature macrophages and into an alternative IL-4-activated phenotype involved in tissue remodelling and healing. Real-time quantitative Reverse Transcription Polymerase Chain Reaction (PCR) analysis was used to study the changes in the expression of a customized panel of key genes, mainly cytokines, receptors and transcription factors. On macrophages differentiated towards the wound healing phenotype, A. montana affected the expression of several genes. In particular CXC chemokine ligand 1 (CXCL1), coding for an chief chemokine, exhibited the most consistent increase of expression, while also CXC chemokine ligand 2 (CXCL2), Interleukin8 (IL8) and bone morphogenetic protein (BMP2) were slightly up-regulated, suggesting a positive influence of A. montana on neutrophil recruitment and on angiogenesis. MMP1, coding for a metalloproteinase capable of cleaving extracellular matrix substrates, was down-regulated. Most results showed non-linearity of the dose-effect relationship. This exploratory study provides new insights into the cellular and molecular mechanisms of action of A. montana as a promoter of healing, since some of the genes it modifies are key regulators of tissue remodelling, inflammation and chemotaxis.

: Homeopathic Rhus toxicodendron treatment increased the expression of cyclooxygenase-2 in primary cultured mouse chondrocytes

What is the fastest way to cure neck and head pain?

Ease muscle tension – Tense muscles can trigger tension-type headaches. Apply heat to relieve tense neck and shoulder muscles. Use a heating pad set on low, a hot water bottle, a hot shower or bath, a warm compress, or a hot towel. Or apply ice or a cool washcloth to the forehead.

What is the reason for neck pain and headache?

Various conditions, such as infections, stress, and illness, can cause neck pain and a headache. Although people can usually manage symptoms at home, they may need to contact a doctor in some cases. People sometimes worry that a headache means they have cancer or another serious medical issue.

• Most headaches, though, are harmless and go away on their own.
• Monitoring for other symptoms, such as fever, and tracking whether or not symptoms get worse can tell a person if they should seek medical attention.
• Read more to learn about what causes neck pain and headache, how to treat the symptoms, and when to contact a doctor.

There are many different types of headaches. The most common are migraine, cluster, and tension.

What pressure point relieves headache and neck pain?

Shoulder well pressure point (Gallbladder 21) – The shoulder well (GB 21) is located at the edge of your shoulder, halfway between your shoulder point and the base of your neck. To use this pressure point:

1. Use the thumb of one hand to apply firm, circular pressure to this point for 1 minute.
2. Then switch and repeat on the opposite side.

Applying firm touch to the shoulder well pressure point can help relieve stiffness in your neck and shoulders, relieving neck pain and preventing headaches caused by this kind of sensation. While using pressure points to treat headaches isn’t well studied, there’s some limited research suggesting that massage of the head and shoulders can help relieve headaches.